New approach to reduce risk of developing type 2 diabetes trialled in Liverpool

(University of Liverpool) An international clinical trial conducted by the University of Liverpool has shown that the drug liraglutide 3.0 mg may reduce diabetes risk by 80 percent in individuals with obesity and prediabetes according to a study published today in The Lancet.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2kNVjN5